Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)

Clinical trial NCT05497843 · COMPLETED

Trial details

NCT number: NCT05497843
Sponsor: Chipscreen Biosciences, Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma

Start date: 2022-08-25
Primary completion: 2025-01-03
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.